PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465578
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1465578
Amniotic Membrane Market - By Product (Cryopreserved, Lyophilized), Application (Surgical Wounds, Ophthalmology, Stem Cell Biology, Regenerative Medicine, Prenatal Diagnosis), End-use (Hospitals, Specialty Clinics) - Global Forecast, 2024 - 2032
Global Amniotic Membrane Market will register 11.2% CAGR from 2024 to 2032, attributed to advancements in tissue engineering and regenerative medicine technologies, coupled with the growing adoption of amniotic membrane products. These innovations offer promising solutions for wound healing and tissue repair across various medical specialties. With versatile applications in ophthalmology, orthopedics, and wound care, amniotic membranes are increasingly favored for their regenerative properties. As awareness grows and healthcare professionals witness the benefits firsthand, the demand for these advanced therapies will fuel the growth of the amniotic membrane industry.
For instance, in November 2022, Versea introduced the Biovance 3L ocular tri-layer human amniotic membrane, offering advanced regenerative capabilities for ophthalmic applications.
The amniotic membrane market is classified based on product, application, end-use, and region.
The ophthalmology segment will amass considerable gains by 2032, propelled by the rising prevalence of ocular disorders and the increasing adoption of amniotic membrane products for ophthalmic surgeries. With advancements in eye care technology, these membranes offer effective treatment for conditions like corneal ulcers and conjunctivitis. Ophthalmologists favor these products for their regenerative properties and ability to promote healing. As demand for innovative eye care solutions rises, the ophthalmology segment will maintain its dominance in the amniotic membrane industry.
The amniotic membrane industry size from the specialty clinics segment will secure a substantial valuation by 2032 due to the increasing number of specialized clinics dedicated to advanced wound care and regenerative medicine. These clinics offer a focused approach to treating various conditions using amniotic membrane products. With a surge in patient preference for minimally invasive procedures and the effectiveness of these membranes in wound healing, specialty clinics are at the forefront. Their commitment to providing specialized care will contribute significantly to their dominance in the market.
Asia Pacific amniotic membrane industry will grow at a notable CAGR between 2024 and 2032, fueled by factors such as the rising number of surgeries, increasing awareness about the benefits of amniotic membrane products, and the growing healthcare infrastructure. Countries like China and India are key contributors to this growth, with their large patient populations and expanding healthcare facilities. Additionally, the region's focus on research and development will further solidify Asia Pacific's position as the pivotal contributor to the amniotic membrane market.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing demand for regenerative medicine
- 3.2.1.2 Rising incidence of chronic wounds
- 3.2.1.3 Advancements in biotechnology and tissue engineering
- 3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Limited shelf life of amniotic membrane products
- 3.2.2.2 Stringent regulatory polices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Cryopreserved
- 5.3 Lyophilized
Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Surgical wounds
- 6.3 Ophthalmology
- 6.4 Stem cell biology
- 6.5 Regenerative medicine
- 6.6 Prenatal diagnosis
- 6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers (ASCs)
- 7.4 Specialty clinics
- 7.5 Research and academic institutes
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Alliqua BioMedical Inc.
- 9.2 Alynx, Co.
- 9.3 Amnio Technology, LLC
- 9.4 Applied Biologics LLC
- 9.5 BioTissue Holdings Inc.
- 9.6 Corza Health, Inc.
- 9.7 Integra LifeSciences Corporation
- 9.8 Organogensis, Inc.
- 9.9 Skye Biologics, Inc.
- 9.10 TissueTech, Inc.
